跳至主要内容
临床试验/NCT04263935
NCT04263935招募中不适用

Correlation Between Driver Gene Abnormalities and Clinicopathological Characteristics and Disease Prognosis in Lymphoma

Henan Cancer Hospital1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2019年1月3日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
200
试验地点
1
主要终点
Incidence of driver gene abnormalities

研究概览

简要总结

Correlation Between Driver Gene Abnormalities and Clinicopathological Characteristics and Disease Prognosis in Lymphoma

详细描述

This trial is a prospective non-interventional observational study. The Chinese patients with lymphoma were included and the study data on driver gene abnormalities, demographic characteristics, clinicopathological characteristics and treatment were collected to evaluate the relevance of efficacy and disease prognosis.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Diagnosed as lymphoma (according to WHO 2017 classification criteria)
  • Life expectancy no less than 3 months
  • Agreeing to sign the written informed consents

排除标准

  • Other malignant tumor history or active malignant tumor need be treated
  • Researchers determine unsuited to participate in this trial

结局指标

主要结局

Incidence of driver gene abnormalities

时间窗: from the day of the first patient was included to the date of the end of this trial, assessed up to 36 months

the incidence of driver gene abnormalities by fixed gene testing technology

次要结局

  • objective response rate(from the date of the first patient was included to the date of the end of this trial, assessed up to 36 months)
  • 5-year overall survival(from the date of the first patient was included to the date of the end of this trial, assessed up to 5 years)
  • Clinicopathological Characteristics(from the date of the first patient was included to the date of the end of this trial, assessed up to 36 months)

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Yanyan Liu

Director

Henan Cancer Hospital

研究点 (1)

Loading locations...

相似试验